Ellacor is a new technology called fractional micro-coring and is a non-surgical solution for mid-to-lower face wrinkles and excess skin. Dr. Michael Cameron, a board-certified dermatologist with a private practice on the upper west side of Manhattan and an assistant clinical professor at Mount Sinai Health System, has one of the few devices commercially available in New York City. Ellacor is an option for patient who want to avoid surgery but address jowels or your heavy lower face. He talks with Michelle about this and how it compares to other cosmetic options.

It’s hard to believe but back-to-school season is already upon us and now is the perfect time to equip your kids with everything they need to take on the new school year. Justine Santaniello, Lifestyle & Parenting Expert, helps alleviate the stress that comes with back-to-school prep and share ways that parents can set their kids up for success at the start of the new school year. Justine will also provide tips on preparing fun lunch and snack ideas, time saving hacks, how to stay organized, and more!

Diggerland USA is the only construction theme & water park in the US. Families can drive, ride & operate real machines in a safe, clean and fun gated theme park. During the summer months, guests can splash, soak and slide at The Water Main water park, nestled inside the theme park and included in admission. Children over 36” tall can enjoy most rides in the park with an accompanying adult. Along with over 40+ rides and attractions, the park also offers a full-service arcade, cafes, gift shop with unique merchandise, eating pavilions, cabana rentals and more.
The park was started in 2014 by brothers, Ilya and Yan Girlya, who had previously been in the construction industry and wanted to find a way for families to enjoy construction machines and increase awareness in the general field. Michelle talks with Ilya about how unique this park is and what a blast it was for her family!

Dr. Mothaffar F. Rimawi is a Professor of Medicine, co-Leader of the Breast Cancer Research Program, and Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine. Metastatic breast cancer (mBC) is the most serious form of the disease and occurs when the cancer has spread beyond the breast to other parts of the body, such as the brain, bones, or liver.1 mBC has no cure and takes a life in the United States approximately every 12 minutes, creating an urgent need for treatment proven to extend life while maintaining quality of life.

Despite remaining gaps, there have been important advancements in treatment for patients with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) mBC. For example, KISQALI® (ribociclib), a prescription medicine indicated for HR+/HER2- mBC in combination with endocrine therapy (ET), has consistently demonstrated across three phase III clinical trials a significant benefit in overall survival (OS) – the length of time that patients diagnosed with mBC continue to be alive – while preserving or improving quality of life.